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 Intrauterine growth restriction (IUGR) creates altered programming in many 
organs, including the hypothalamus. Programming involves adaptive changes initiated to 
protect the survival of a fetus following IUGR, which can adversely influence the later 
response of genes that regulating energy balance. In male mice, IUGR coupled with rapid 
postnatal catch-up growth predisposes towards early onset obesity. One potential 
mechanism for this obesity is altered hypothalamic programming of intrahypothalamic 
cues involving prepro-orexin and prepro-MCH, two energy balance regulating genes as 
well as the extra-hypothalamic cues of peripheral hormones leptin and insulin. We 
therefore hypothesized that IUGR would alter hypothalamic programming of prepro-
orexin and prepro-MCH genes in association with altered serum leptin and insulin levels 
in male mice at postnatal day 7 (P7) and P60.  
IUGR was induced via maternal thromboxane A2-analog infusion in the last week 
of C57BL/6J mouse gestation. Sham operated dams acted as controls. Sham and IUGR 
offspring were cross-fostered to unmanipulated dams and weaned to standard mouse 
chow at P21. In this mouse model, IUGR males, as compared to IUGR females, achieve 
rapid catch-up growth to sham males by P28 whereas IUGR females do not catch-up to 
sham females until P77. We measured mRNA levels via quantitative real-time RT-PCR, 
protein levels via Western immunoblotting, serum leptin and insulin levels via ELISA, 




IUGR increased hypothalamic prepro-orexin protein levels and decreased MCH 
mRNA levels in P7 IUGR males. In conclusion, our findings of IUGR-induced altered 
hypothalamic programming of prepro-orexin and prepro-MCH are gender-specific and do 
not persist in the neonatal period, but into adulthood. Altered programming of genes such 
as prepro-orexin and prepro-MCH in the neonatal period may contribute to the 
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Intrauterine Growth Restriction 
 The obesity epidemic is escalating disproportionately in the United States for 
adults, and now for children and adolescents (1,2).  One identified predisposing factor for 
early onset obesity among children and adolescents is intrauterine growth restriction 
(IUGR) (3).  IUGR occurs when a decrease in transplacental transfer of oxygen and 
nutrients occurs in the fetus (5).  The altered prenatal environment causes subsequent 
changes in gene expression to ensure survival of the fetus (6).  These adaptive changes, 
however, have been shown to impact metabolic processes that lead to an increased risk of 
postnatal obesity, as well as other co-morbidities such as type 2 diabetes, cardiovascular 
disease, and insulin resistance (3,4,6).  Furthermore, IUGR coupled with rapid postnatal 
catch-up growth, strongly predicts an earlier onset of obesity (16).  The connection 
between IUGR and obesity is well-demonstrated in human and animal models of IUGR 
(7). 
 The concept that a prenatal insult, such as IUGR, can manifest adult onset disease, 
such as obesity, is referred to as programming, and is a phenomenon that is well 
described in animals and humans. Programming generally refers to adaptive changes 
made to ensure survival in the perinatal environment profoundly impacting the final 
phenotype throughout life. These adaptive changes can adversely impact many organs, 
including the brain (3,8).  Within the brain, the hypothalamus has an established role in 
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controlling energy balance (3).  Therefore, any IUGR- induced programming that may 




 The hypothalamic neurons and axons that aid in energy balance regulation 
develop during perinatal life in rodents (3).  During this critical time of development, 
external and internal cues influence hypothalamic programming and influence the final 
phenotype.  Intra-hypothalamic cues also help to organize the hypothalamus. These cues 
refer to the actual neurons that make up the arcuate nucleus ARC of the hypothalamus. 
The ARC is anatomically posed to act as the main hub in the hypothalamus regarding 
energy balance (10).  The area of interest for this study is the lateral hypothalamic area 
(LHA) which receive projections from the ARC. The LHA contains two populations of 
neurons that produce orexigenic neuropeptides which impact energy homeostasis in 
humans and rodents (13). One group produces orexin, while the other produces melanin 
concentrating hormone (MCH) in both humans and rodents (3,11,12). 
 Extra-hypothalamic cues include hormones released from peripheral organs such 
as leptin produced by adipocytes and insulin produced by the pancreas.  Both leptin and 
insulin are integral in creating a normally functioning hypothalamus in animals and 
humans (3).  An appropriate leptin surge at the correct time is essential in the early 
neonatal environment to solidify hypothalamic circuits; thereby ensuring appropriate 
signaling or programming for normal energy homeostasis in rodents (3, 9,17,19).  
Additionally, if increased levels of insulin occur during hypothalamic development, 
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obesity and unfavorable neuronal morphology to the hypothalamic ARC is evident in 
rodents (3,17). 
 
Orexin and Melanin Concentrating Hormone 
 Orexin, also known as hypocretin, encompasses both orexin A and orexin B 
neuropeptides. Both neuropeptides are produced from a common precursor polypeptide 
named prepro-orexin (12). Orexin A and B bind to two specific-G-protein-coupled 
receptors, OX1R and OX2R for downstream signaling (12,13).  Similarly, MCH is 
produced from an MCH precursor and interacts with two specific-G-protein-coupled 
receptors, MCH1R and MCH2R (11,14,20).  For the purpose of this project, we will only 
examine the levels of hypothalamic prepro-orexin and prepro-MCH, acknowledging that 
both receptors are present throughout the brain and are required for cellular action (12).  
Neurons that contain orexin in the LHA in humans and rodents have been shown to be 
sensitive to changes in nutrient levels; in fact, while in the fed state hyperpolarization and 
cessation of action potentials occurs in orexin neurons to decrease signal for nutrients 
(12).  Furthermore, in studies involving prepro-orexin knockout mice, they ate less and 
had a decrease in energy expenditure leading to weight gain when compared to control 
mice, demonstrating prepro-orexin’s role in energy balance (13).  Similarly, MCH 
knockout mice showed evidence of resistance to diet-induced obesity as well as increased 
energy expenditure and locomotor activity as compared to control mice (10,15). 
 
IUGR Mouse Model 
 Animal models are useful tools in dissecting mechanism of all diseases, including 
obesity.  One such animal model showed that IUGR rats developed obesity following a 
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rapid, postnatal catch-up growth at the beginning of life (19).  In our lab, we have also 
demonstrated such catch-up growth in a newly developed mouse model.  In this mouse 
model, IUGR males, who are 15 percent lighter than controls at birth,  achieve rapid 
catch-up growth to that of sham males by postnatal day 28 (P28) whereas IUGR females 
do not catch-up to sham females until P77.  Additionally, IUGR males begin to exhibit 
overt obesity - as they surpass sham males in weight at P238 (8 1/2 months) whereas 
IUGR females do not surpass sham females in weight up to one year of age (8). 
 
Hypothesis 
We hypothesized that IUGR would alter hypothalamic programming of prepro-
orexin and prepro-MCH genes in association with altered serum leptin and insulin levels 
















II. METHODOLOGY/RESEARCH DESIGN 
 
 
Animal Model  
 The model for this project is a mouse model of chronic uteroplacental 
insufficiency achieved via micro-osmotic pump infusion of thromboxane A2 during the 
last week of C576BL/6J mouse gestation (8).  The resultant maternal phenotype mimics 
complications of human preeclampsia, which is a condition of pregnancy-induced 
hypertension.  When compared to sham-operated pups, IUGR pups show an altered 
metabolic profile in the blood, and display altered hepatic gene expression in genes 
important for growth and metabolism.  
 C57BL/6J male and female mice were mated.  At embryonic day 12.5, pregnant 
females were anesthetized for micro-osmotic pump insertion (model 1007D, 0.5μl/hr, 
Durect Corporation, Cupertino, CA). Pumps in sham-operated mothers were filled with 
vehicle (0.5% ethanol) whereas pumps in IUGR mothers were filled with U-46619, a 
thromboxane A2 (TXA2) analog, dissolved in 0.5% ethanol. Pups were allowed to deliver 
spontaneously and cross-fostered to unmanipulated dams until weaning. Pups were 
separated into the following groups: IUGR males (IM), sham males (SM), IUGR females 
(IF), and sham females (SF). Each group included 6-8 pups, with 1-2 pups derived from 
different litters, in order to maximize litter-to-litter variation.   Blood and hypothalami 




RNA Isolation, cDNA Synthesis, RT-PCR for 
Orexin and MCH mRNA Levels 
 Genomic-free total RNA was isolated from P7 and P60 hypothalami of sham and 
TXA2 -induced IUGR mice using NucleoSpin RNA XS protocol and NucleoSpin RNA II 
protocol (Clontech Laboratories, Mountain View, CA) respectively. Total RNA 
concentration was quantified with Biotek Epoch spectrophotometer (Biotek instruments, 
Winooski, Vt); RNA integrity was then verified by RNA denaturing gel electrophoresis.   
  cDNA was synthesized for 4 ug of total RNA using random hexamers from a 
High-Capacity cDNA Archive kit (Applied Biosystemsm, Foster City, CA). Using real-
time RT-PCR, P7 and P60 prepro-orexin and prepro-MCH mRNA levels were 
determined. All primers and probes for real-time RT-PCR were available from Taqman 
Assays-on-Demand with assay identification numbers of rn00565995_m1 (orexin) and 
mm01242886_g1 (MCH). Dye emission was detected using an automated sequence 
detector, ABI Prism 7900HT Sequence Detection System (SDS), in conjunction with its 
software version 2.1 (Applied Biosystems, Foster City, CA). Each Sample was run in 
quandruplicates. Relative quantitation comparing 2-∆Ct (Applied Biosystems, Foster City, 
CA) values were used to analyze changes in gene expression between sham and IUGR 
pups with GAPDH as a loading control.  To validate GAPDH as an appropriate loading 
control, parallel serial dilutions between sham and IUGR cDNA were quantified as 
described previously. We also ensured that the amplification efficiencies between the 







Prepro-orexin and Prepro-MCH Protein Levels 
 Hypothalami obtained from P7 and P60 sham and TXA2 mice were lysed in 
RIPPA buffer to prepare total protein fractions for western immunoblotting.  Total 
protein concentration was determined via BCA Protein Assay (Pierce Biotechnology, 
Rockford, IL) using bovine serum albumin (BSA) as standards. Protein and molecular 
weight markers were loaded for immunoblotting as follows: 10 uL molecular weight 
marker, P7 prero-orexin females and males: 100 ug, 30 ug protein; P60 prepro-orexin 
females and males: 30 ug protein; P7 prepro-MCH females and males: 150 ug protein; 
and P60 prepro-MCH females and males: 150 ug, 100 ug protein. Proteins were separated 
by gel electrophoresis with 16.5% Tris-Tricine/Peptide 1.0 mm Criterion gels (Bio-Rad 
Laboratories, Hercules, CA) at 150V for 30 minutes.  After electrophoresis, protein was 
transferred to polyvinylidene flouride membranes for P60 orexin (Millipore Corporation, 
Billerica, MA) and nitro-cellulose membranes (Pall Life Sciences, Ann Harbor, MI) for 
the remaining proteins, for 30 minutes on ice. Post-transfer, membranes were blocked in 
5% milk/Tris-buffered saline Tween (TBS-T) at RT for 1-1.5 h and washed in 1X TBS-T 
after blocking is complete. Bound proteins were then detected with antibodies against 
orexin (Millipore, Temecula, CA) and MCH (Millipore, Temecula, CA). GAPDH (Cell 
Signaling Technology, Danvers, MA) served as the loading control. Blots were incubated 
with each primary antibody at 4 C overnight.  After multiple washes in TSB-T, 
membranes were probed with secondary antibody for 1 h at RT. After washing 
thoroughly with TBS-T, antibody signals were detected by Western Lighting enhanced 
chemiluminescence (PerkinElmer, Waltham, MA) and quantified with Kodak Image 




 Serum leptin levels were measured at P7 and P60 using RayBio Mouse Leptin 
ELISA kit (ELM-Leptin-001, RayBiotech, Inc., Norcorss, GA). Using the quantitative 
sandwich enzyme immunoassay technique, standards with 3.6 uL P7 serum for 1:100 
dilution and 2 uL P60 serum for 1:250 dilution were pipetted into wells that were coated 
with polyclonal antibody specific for mouse leptin. Any serum mouse leptin would be 
bound by the antibody within the wells. Next, enzyme-linked secondary polyclonal 
antibody for mouse leptin were pipetted into the wells.  A substrate solution was then 
added to create a colorimetric reaction that could be measured by a spectrophotometer at 
450 nm. Absorbance values of known leptin standards were then plotted against leptin 
concentration on a linear-regression standard curve. 
 
Insulin 
 Serum insulin levels were measured at P7 and P60 using Mercodia Ultrasensitive 
Mouse Insulin ELISA kit (10-1249-01, Sylveniusgatan, Sweden). This ELISA employs a 
solid phase two-site sandwich enzyme immunoassay technique, in which two monoclonal 
antibodies are directed against separate antigens on the insulin molecule. Fifty uL of each 
serum sample in duplicates along with known concentrations of insulin standards were 
incubated with peroxidase-conjugated anti-insulin antibodies bound to microtitration 
wells. Unbound enzyme-labeled antibody was washed away. Bound conjugate were then 
detected by reaction with 3,3’,5,5’-tetramethylbenzidine to give a colorimetric endpoint 
that was read spectrophotometrically at 450 nm. Absorbance values of known insulin 





 Due to the potential of prepro-orexin and prepro-MCH levels to alter food intake 
we measured food intake during the period of the study where IUGR pups were 
consuming rodent chow. Pups were weaned at P21 and placed in individual cages. 
Regular mouse chow consumption was measured from P21 to P60. Of note, we could not 
measure food intake prior to weaning as the necessary handling of the pups would 
contribute to maternal rejection of the pups. 
 
Statistics 
Data were expressed as means±SEMs (standard error of the means). RT-PCR and 
ELISA data were analyzed with ANOVA with Fisher's protected least significance 
difference (PLSD) post-hoc test. Protein expression data were analyzed using the Mann-
























Hypothalamic Prepro-Orexin mRNA Levels 
In IUGR and Sham Offspring at P60 
Prepro-orexin mRNA levels were undetectable in IUGR pups at P7 (data not 
shown). Prepro-orexin mRNA levels also proved to be undetectable in sham pups at P7 
(data not shown). IUGR did not alter prepro-orexin mRNA levels in males and females 









Hypothalamic Prepro-orexin Protein Levels In IUGR and 
Sham Offspring At P7 and P60 
Despite undetectable hypothalamic prepro-orexin mRNA levels, IUGR increased 
prepro-orexin protein levels in males as compared to sham males at P7 (Figure 2). IUGR, 
however, did not alter prepro-orexin protein levels in females as compared to sham 
females at P7. IUGR did not affect prepro-orexin protein levels in either males or females 









Hypothalamic Prepro-MCH mRNA Levels In IUGR and 
Sham Offspring At P7 and P60 
IUGR decreased prepro-MCH mRNA levels in males as compared to sham males 
at P7 (Figure 3). IUGR did not alter prepro-MCH mRNA levels in females as compared 
to sham females at P7. IUGR did not alter prepro-MCH mRNA levels in males and 












Hypothalamic Prepro-MCH Protein Levels In IUGR and 
Sham Offspring At P7 and P60 
IUGR did not affect prepro-MCH protein levels in either males or females as 
compared to sham males and females at P7 (Figure 4).  IUGR continued to have no effect 
on prepro-MCH protein levels in males and females as compared to sham males and 










Serum Leptin Levels In IUGR and Sham 
Offspring at P7 and P60 
IUGR did not alter serum leptin levels at P7 relative to sham pups (Figure 5).  
IUGR continued to have no effect on serum leptin levels in males and females as 
compared to sham pups at P60 (Figure 5).  However, serum leptin levels in IUGR males 











Serum Insulin Levels In IUGR and Sham 
Offspring at P7 and P60 
IUGR did not alter serum insulin levels in males and females as compared to 
sham pups at P7 in this IUGR mouse model (Figure 6).  IUGR continued to have no 
effect in males and females as compared to sham offspring at P60 in this IUGR mouse 












Food Intake In IUGR and Sham Offspring 
From P21-P60 
IUGR male offspring consumed similar amounts of food compared to sham male 
offspring respectively from P21-P60 (Figure 7).  Furthermore,IUGR female pups as 
compared to sham female offspring also consumed similar amounts of food from P21-

















The most significant finding of this project is that IUGR alters hypothalamic 
programming of prepro-orexin and prepro-MCH genes at P7 in IUGR male mice, 
potentially providing a mechanism for the rapid postnatal catch-up growth achieved in 
these IUGR males at P28.  These findings agree with the current concept that IUGR can 
affect hypothalamic programming (3). However, to our knowledge, these findings are the 
first findings demonstrating that IUGR specifically affects the prepro-orexin- and prepro-
MCH-producing neurons within the lateral hypothalamus in a gender-specific manner.  
The increased prepro-orexin protein levels in IUGR male mice compared to sham 
male mice at P7 signify that IUGR has altered hypothalamic development leading to a 
maladjusted energy axis.  Prepro-orexin levels are known to increase during a 
hypoglycemic state in rats (12).  However, our P7 mouse pups are nursed by their cross-
fostered dams up to the time of sacrifice, showing that despite having a normally fed 
state, prepro-orexin protein levels are still elevated over sham levels in IUGR males. 
Interestingly, IUGR females showed no such prepro-orexin protein increase compared to 
sham females at P7 despite being similarly nursed as IUGR males. The underlying 
mechanism behind this gender difference is unclear at this time. We are however 
intrigued by this gender disparity and speculate that altered testosterone to estradiol 
balance in the brain may be responsible for the dysregulation seen in IUGR males. We 
know from another IUGR model that IUGR males have increased serum testosterone
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levels and decreased aromatase expression in the hippocampus of the brain (21).  
Aromatase is the enzyme responsible for the conversion of testosterone to its metabolite 
estradiol. The exposure of the developing hypothalamus to an improper 
testosterone:estradiol ratio may hinder its proper development to result in altered 
hypothalamic programming. 
 The decrease in prepro-MCH mRNA levels in P7 IUGR male mice as compared 
to sham mice provides another piece of evidence that IUGR alters hypothalamic 
programming in our model.   The discrepancy between prepro-MCH mRNA and protein 
levels could reflect altered mRNA or protein stability in P7 IUGR males. While the 
mechanism behind this finding requires further investigation, it further demonstrates 
IUGR induced hypothalamic programming in IUGR males.  
The extra-hypothalamic leptin surge is essential to placement and further 
development of leptin receptors and neuronal growth (3).  If this leptin surge occurs 
prematurely, hypothalamic organization is altered (3,18).  In our model, IUGR males 
exhibited a trend of increased serum leptin levels at P7, and while the increase did not 
reach statistical significance, the increase is likely biologically significant. 
Reinvestigation with an increased sample size may demonstrate significance. A 
premature leptin surge in mice before P14 is known to decrease the anorexigenic gene 
expression of proopiomelanocortin (POMC), thereby establishing dysfunctional 
programming and signaling in the hypothalamus  thereby producing a phenotype prone to 
rapid, catch-up growth (3,18), such as that observed in our model. IUGR did not elicit 
changes in hypothalamic prepro-orexin and prepro-MCH mRNA or protein levels, serum 
leptin and insulin levels, and food intake in either gender at P60. The interpretation here 
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is different from P7 because these genes at P60 have a greater role in governing food 
intake than hypothalamic development; therefore these results show that food intake is 
not the perturbed mechanism for increased catch-growth in IUGR males. 
 We recognize that certain limitations exist in our study.  We have examined 
prepro-orexin and prepro-MCH mRNA and protein levels; however, to further elucidate 
the effects of these ligands, we need to investigate orexin and MCH receptors as well as 
the downstream targets of those receptors to provide a more complete picture of the 
orexin and MCH system in these IUGR pups.  Furthermore, milk intake could not be 
measured from P0-P21 thereby limiting information on actual caloric intake of the IUGR 
male pups as compared to sham male pups during this critical time of rapid catch-up 
growth.  Additionally, hypothalamic development time points differ between mice and 
humans. While similar programming may occur in both species, all of human 
hypothalamic development occurs in utero while murine hypothalamic development 
spans the end of gestation into the first weeks of postnatal life, therefore data cannot be 
extrapolated directly to humans (3).  The major benefit of using an animal model, 
however, is the allowance for exploration of mechanisms of disease in a compressed 
developmental time span which would otherwise take years to achieve in humans.   
 In summary, IUGR’s alterations to hypothalamic programming contribute to a 
phenotype destined for obesity and its co-morbidities (3).  Limited knowledge currently 
exists regarding hypothalamic programming and development in humans, giving rise to 
the importance of examining all alterations to hypothalamic changes in an animal model 
that occur as a result of IUGR. Only by understanding the mechanisms behind IUGR-
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